Seguir
Ivana Maida
Ivana Maida
Afiliación desconocida
Dirección de correo verificada de uniss.it
Título
Citado por
Citado por
Año
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
P Labarga, V Soriano, ME Vispo, J Pinilla, L Martín-Carbonero, ...
The Journal of infectious diseases 196 (5), 670-676, 2007
2252007
Severe liver disease associated with prolonged exposure to antiretroviral drugs
I Maida, M Núñez, MJ Ríos, L Martín-Carbonero, G Sotgiu, C Toro, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (2), 177-182, 2006
2122006
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy
S Babudieri, B Longo, L Sarmati, G Starnini, L Dori, B Suligoi, ...
Journal of medical virology 76 (3), 311-317, 2005
1662005
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
E Vispo, P Barreiro, JA Pineda, JA Mira, I Maida, L Martín-Carbonero, ...
Antiviral therapy 13 (3), 429-438, 2008
1542008
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine
A Barrios, A Rendón, E Negredo, P Barreiro, T Garcia-Benayas, ...
Aids 19 (6), 569-575, 2005
1372005
Rickettsia monacensis as cause of Mediterranean spotted fever–like illness, Italy
G Madeddu, F Mancini, A Caddeo, A Ciervo, S Babudieri, I Maida, ...
Emerging infectious diseases 18 (4), 702, 2012
1222012
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings
E Vispo, A Moreno, I Maida, P Barreiro, A Cuevas, S Albertos, V Soriano
Aids 24 (8), 1171-1176, 2010
1122010
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
I Maida, P Garcia-Gasco, G Sotgiu, MJ Rios, ME Vispo, ...
Antiviral Therapy 13 (1), 103-108, 2008
1122008
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver international 37 (4), 514-528, 2017
992017
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies
V Soriano, I Maida, M Núñez, J García-Samaniego, P Barreiro, ...
Antiviral therapy 9 (6), 987-992, 2004
972004
HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications
M Andreoni, A Giacometti, I Maida, P Meraviglia, D Ripamonti, L Sarmati
Eur Rev Med Pharmacol Sci 16 (11), 1473-1483, 2012
932012
Serum homocysteine levels are increased in women with gestational diabetes mellitus
G Seghieri, MC Breschi, R Anichini, A De Bellis, L Alviggi, I Maida, ...
Metabolism 52 (6), 720-723, 2003
932003
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
P Garcia-Gasco, I Maida, F Blanco, P Barreiro, L Martín-Carbonero, ...
Journal of antimicrobial chemotherapy 61 (3), 699-704, 2008
912008
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands.
F Vitale, DV Briffa, D Whitby, I Maida, A Grochowska, A Levin, N Romano, ...
872001
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
G Mameli, G Madeddu, A Mei, E Uleri, L Poddighe, LG Delogu, I Maida, ...
PLoS One 8 (11), e78474, 2013
862013
Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian observational study (ItaliCO)
F Polverino, DA Stern, G Ruocco, E Balestro, M Bassetti, M Candelli, ...
Frontiers in cardiovascular medicine 7, 585866, 2020
812020
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin
MG Antonini, S Babudieri, I Maida, C Baiguera, B Zanini, L Fenu, G Dettori, ...
Infection 36, 250-255, 2008
802008
Modulation by α-and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells∗
F de Nigris, F Franconi, I Maida, G Palumbo, V Anania, C Napoli
Biochemical pharmacology 59 (11), 1477-1487, 2000
752000
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
A De Vito, V Fiore, E Princic, N Geremia, CM Panu Napodano, ...
PLoS One 16 (3), e0248009, 2021
732021
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C
E Vispo, A Mena, I Maida, F Blanco, M Cordoba, P Labarga, ...
Journal of antimicrobial chemotherapy 65 (3), 543-547, 2010
722010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20